8-K: Versus Systems Secures $2.5 Million Investment from ASPIS Cyber Technologies

Versus Systems has entered into a funding agreement with ASPIS Cyber Technologies, securing a $2.5 million investment, with an initial $500,000 received and the remainder expected by November 15, 2024.

Summary

• Versus Systems Inc. has secured a $2.5 million investment from ASPIS Cyber Technologies, an affiliate of their largest shareholder, Cronus Equity Capital Group.
• The initial investment of $500,000 was received on October 16, 2024, with the remaining $2 million expected by November 15, 2024.
• In exchange for the investment, Versus Systems issued a senior convertible promissory note to ASPIS.
• Upon shareholder approval and the company's redomiciling to Delaware, the note will automatically convert into units, each consisting of one common share and a warrant to purchase half a common share at $4.00 per share.
• The conversion rate is set at $1.16 per share, or the five-day volume weighted average price of the common shares if higher.
• If the full investment is funded and the conversion occurs, ASPIS would receive 2,155,172 common shares and warrants for an additional 1,077,586 shares, resulting in approximately 43.6% ownership of Versus Systems.
• The promissory note bears a 10% annual interest rate and matures one year from issuance if not converted.
• The company also received $885,003.20 from the exercise of 240,490 warrants from a previous offering.

Sentiment

Score: 6

Explanation: The investment is a positive development, but the potential dilution and dependence on shareholder approval create some uncertainty. The company also faces risks related to Nasdaq compliance.

Positives

• The $2.5 million investment provides Versus Systems with significant funding.
• The conversion of the promissory note into equity could strengthen the company's balance sheet.
• The exercise of warrants generated $885,003.20 in additional capital for the company.
• The investment from ASPIS, an affiliate of the largest shareholder, indicates confidence in the company's future.

Negatives

• The conversion of the note will significantly dilute existing shareholders, with ASPIS potentially owning 43.6% of the company.
• The promissory note has a 10% interest rate, which could be a financial burden if not converted.
• The note becomes due in one year if the company fails to redomicile to Delaware, creating a potential repayment obligation.
• The company is dependent on shareholder approval for the conversion and redomiciling to Delaware.

Risks

• The company's ability to regain compliance with Nasdaq listing rules is uncertain, and delisting could negatively impact the share price and ability to obtain financing.
• The company's reliance on ASPIS for funding could create a dependency.
• The conversion of the note is contingent on shareholder approval and redomiciling to Delaware, which may not occur.
• The company faces risks related to changes in business strategy or plans.

Future Outlook

The company's future is dependent on shareholder approval for the conversion of the promissory note and the redomiciling to Delaware. The company also needs to regain compliance with Nasdaq listing rules to avoid delisting.

Management Comments

• The document does not contain any direct quotes from management, but it does outline the terms of the agreement and the company's plans.

Industry Context

The investment from ASPIS, a cybersecurity company, could indicate a strategic move by Versus Systems to explore opportunities in the gaming and social media sectors, where cybersecurity is increasingly important. This could be a move to diversify their business and leverage the expertise of their largest shareholder's affiliate.

Comparison to Industry Standards

• The terms of the convertible note, including the 10% interest rate and the conversion rate of $1.16, are within the typical range for similar financings in the small-cap technology sector.
• The potential dilution of existing shareholders to 43.6% is significant, but not uncommon in early-stage companies seeking substantial capital.
• The warrant exercise price of $4.00 per share is a premium to the conversion price, which is typical for warrants issued in conjunction with convertible notes.
• The requirement for shareholder approval and redomiciling to Delaware is a common condition in such transactions, ensuring shareholder oversight and alignment with corporate governance best practices.

Related Party Transactions

• The investment from ASPIS is a related party transaction, as ASPIS is an affiliate of the company's largest shareholder, Cronus Equity Capital Group.
• One of the company's directors is also a shareholder and board member of ASPIS.

Stakeholder Impact

• Shareholders will experience dilution if the promissory note is converted.
• The investment provides the company with capital to continue operations and pursue growth opportunities.
• The company's ability to regain compliance with Nasdaq listing rules will impact the share price and investor confidence.

Next Steps

• The company needs to obtain shareholder approval for the conversion of the promissory note and the redomiciling to Delaware.
• The company needs to complete the remaining $2 million investment from ASPIS by November 15, 2024.
• The company needs to file the Subscription Agreement and form of Warrant as exhibits to its next Quarterly Report on Form 10-Q.
• The company needs to regain compliance with Nasdaq listing rules.

Key Dates

Keywords

investment, funding, convertible note, shareholder approval, redomiciling, ASPIS, warrants, common shares, dilution, Nasdaq